Quantcast

Latest Atomoxetine Stories

2014-07-02 23:06:10

BCC Research (http://www.bccresearch.com) is pleased to announce the BCC Research Strattera® Forecast, a strategic investment product designed to provide market data for the pharmaceutical drug, Strattera®, a treatment for Attention Deficit Hyperactivity Disorder (ADHD) distributed by Eli Lilly and Company. Strattera® will lose its branded patent protection in late 2016 going into 2017, opening the market to distribution of generic treatments by competing companies....

2014-04-25 08:27:40

WOODCLIFF LAKE, N.J., April 25, 2014 /PRNewswire/ -- Eisai Inc. announced today that six abstracts highlighting data analyses for FYCOMPA(TM) (perampanel) will be presented at the 66(th) annual American Academy of Neurology (AAN) meeting, taking place in Philadelphia, PA from April 26( )- May 3. http://photos.prnewswire.com/prnvar/20120413/MM87168LOGO "Eisai and its epilepsy franchise are committed to expanding its knowledge of current products and developing new medications for the...

FDA Warning Issued On ADHD Drug Due To Painful Priapism
2013-12-17 15:58:44

Brett Smith for redOrbit.com - Your Universe Online A type of stimulant used to treat attention deficit disorders can lead to the development of long-lasting and sometimes painful erections, the Food and Drug Administration (FDA) said in a written warning released on Tuesday. The condition, referred to as priapism, was linked in an FDA review to males between 8 to 33 years of age who took drugs containing methylphenidate, the active ingredient in Ritalin and Concerta. “Patients who...

ADHD Medication Lowers Crime
2012-11-23 05:10:50

Connie K. Ho for redOrbit.com — Your Universe Online A study by British and Swedish researchers recently found that medication for attention deficit-hyperactivity disorder (ADHD) could help reduce some instances of criminal behavior. Medications like Adderall, Ritalin, and other drugs could help limit hyperactivity and elevate the ability to focus. Reuters reports that Ritalin is produced by Novartis, a Swedish drug maker, while companies sell other ADHD drugs like Eli Lilly...

2012-07-12 23:02:47

Methylphenidate prescriptions have increased fourfold in the last decade, and yet estimates as to its effectiveness suggest a sizeable 'gap' where children do not respond to such drug-based treatment. A recent double-blind pilot trial shows a potential natural treatment breakthrough that may help fill this gap for children resistant to medication. Cambridge, UK (PRWEB) July 12, 2012 Recently published clinical research shows a potential ADHD treatment breakthrough using a pure EPA natural...

2012-03-05 23:11:37

Immaturity may lead to diagnosis of disorder The youngest children in the classroom are significantly more likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) – and prescribed medication – than their peers in the same grade, according to a study just published in CMAJ (Canadian Medical Association Journal). ADHD, which is often treated with prescription medication, is the most commonly diagnosed behavioural disorder in children. Two recent studies...

ADHD Drugs Do Not Up Risk For Heart Problems
2011-12-13 06:15:34

Researchers, funded by the U.S. Food and Drug Administration and the Agency for Health Research Quality, recently studied the cardiovascular risk of ADHD medications in adults. The study found little evidence that the medications increased the risk of heart events, such as heart attack, sudden cardiac death, and stroke. The concerns stem from the fact that some of the medications are able to slightly increase heart rate and blood pressure levels. According to the study,...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related